Top Clinical Trials companies in Poland by Return on Assets (ROA)
Poland
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
10.98%
|
Dec. 31, 2023 | USD 10.82 | 1.26% |
|
Poland |
|
| 2 |
-10.66%
|
Dec. 31, 2023 | USD 9.62 | -0.82% |
|
Poland |
|
| 3 |
-13.53%
|
Dec. 31, 2023 | USD 1.87 | 0.85% |
|
Poland |
|
| 4 |
-22.85%
|
Dec. 31, 2023 | USD 6.89 | -1.14% |
|
Poland |
|
| 5 |
-72.55%
|
Dec. 31, 2023 | USD 12.56 | 1.66% |
|
Poland |
Frequently Asked Questions
-
Which Clinical Trials company in Poland has the highest Return on Assets (ROA) ?
The Clinical Trials company in Poland with the highest Return on Assets (ROA) is Selvita S.A. (Warsaw Stock Exchange: SLV.WA) at 10.98%.
-
Which Clinical Trials company in Poland has the lowest Return on Assets (ROA) ?
The Clinical Trials company in Poland with the lowest Return on Assets (ROA) is Captor Therapeutics Spolka Akcyjna (Warsaw Stock Exchange: CTX.WA) at -72.55%.
-
What are the top 10 Clinical Trials companies in Poland by Return on Assets (ROA) ?
The top 10 Clinical Trials companies in Poland by Return on Assets (ROA) are Selvita S.A., Poltreg S.A., Medinice S.A., Ryvu Therapeutics S.A. and Captor Therapeutics Spolka Akcyjna.
-
What are the bottom 10 Clinical Trials companies in Poland by Return on Assets (ROA) ?
The bottom 10 Clinical Trials companies in Poland by Return on Assets (ROA) are Captor Therapeutics Spolka Akcyjna, Ryvu Therapeutics S.A., Medinice S.A., Poltreg S.A. and Selvita S.A..
